Boosting of vaginal HSV-2-specific B and T cell responses by intravaginal therapeutic immunization results in diminished recurrent HSV-2 disease

Mertz KJ, Trees D, Levine WC, Lewis JS, Litchfield B, Pettus KS, Morse SA, St Louis ME, Weiss JB, Schwebke J, Dickes J, Kee R, Reynolds J, Hutcheson D, Green D, Dyer I, Richwald GA, Novotny J, Weisfuse I, Goldberg M, O’Donnell JA, Knaup R. 1998. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The genital ulcer disease surveillance group. J Infect Dis 178:1795–1798.

Leave a Reply